Considering that HDAC6 inhibitors are being investigated as a treatment for pain caused by peripheral neuropathy in multiple disorders, it would be beneficial to determine how HDAC6 inhibition affects diabetic neuropathy (Akude et al., 2011; Benoy et al., 2018; Prior et al., 2018; Cavalli et al., 2019). The gene discussed is HDAC6; the disease is diabetic neuropathy.